Cost-effectiveness of Ivabradine as a Treatment for Systolic Chronic Heart Failure in the United States

被引：0
|
作者：
Kansal, Anuraag R.
Cowie, Martin
Kielhorn, Adrian
Krotneva, Stanimira
Taffazzoli, Ali
Zheng, Ying
Yurgin, Nicole
机构：
来源：
CIRCULATION | 2015年 / 132卷
关键词：
cost effectiveness; systolic chronic heart failure; ivabradine; quality-adjusted life years; hospitalization;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
17655
引用
收藏
页数：4
相关论文
共 50 条
  • [11] Cost-Effectiveness Analysis of Adding Ivabradine to Current Standard Therapy Versus Standard Therapy Alone in Patients with Chronic Heart Failure in Japan
    Inomata, Takayuki
    Fukuda, Takeshi
    Yamashita, Nobuya
    Niibe, Koji
    Demiya, Sven
    Matsuda, Hiroyuki
    Igarashi, Ataru
    INTERNATIONAL HEART JOURNAL, 2024, 65 (06) : 1040 - 1048
  • [12] Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States
    Angus, DC
    Clermont, G
    Watson, RS
    Linde-Zwirble, WT
    Clark, RH
    Roberts, MS
    PEDIATRICS, 2003, 112 (06) : 1351 - 1360
  • [13] Cost-Effectiveness of Quadruple Therapy in Management of Heart Failure With Reduced Ejection Fraction in the United States
    Yan, Brandon W. W.
    Spahillari, Aferdita
    Pandya, Ankur
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2023, 16 (06): : 401 - 410
  • [14] Long-Term Cost-Effectiveness of Disease Management in Systolic Heart Failure
    Miller, George
    Randolph, Stephen
    Forkner, Emma
    Smith, Brad
    Galbreath, Autumn Dawn
    MEDICAL DECISION MAKING, 2009, 29 (03) : 325 - 333
  • [15] Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
    Borer, Jeffrey S.
    Boehm, Michael
    Ford, Ian
    Komajda, Michel
    Tavazzi, Luigi
    Lopez Sendon, Jose
    Alings, Marco
    Lopez-de-Sa, Esteban
    Swedberg, Karl
    EUROPEAN HEART JOURNAL, 2012, 33 (22) : 2813 - 2820
  • [16] The Cost-effectiveness of Eltrombopag for the Treatment of Immune Thrombocytopenia in the United States
    Tremblay, Gabriel
    Dolph, Mike
    Roy, Anuja Nidumolu
    Said, Qayyim
    Forsythe, Anna
    CLINICAL THERAPEUTICS, 2020, 42 (05) : 860 - +
  • [17] Cost-effectiveness of empagliflozin for the treatment of heart failure: a systematic review
    Liu, Jinyu
    Liu, Dong
    Gong, Xuepeng
    Wei, Anhua
    You, Ruxu
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [18] Ivabradine for treatment of heart failure
    Bocchi, Edimar Alcides
    Salemi, Vera Maria Cury
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (05) : 393 - 402
  • [19] Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
    Kourlaba, Georgia
    Parissis, John
    Karavidas, Apostolos
    Beletsi, Alexandra
    Milonas, Charalambos
    Branscombe, Neil
    Maniadakis, Nikos
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [20] Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
    Georgia Kourlaba
    John Parissis
    Apostolos Karavidas
    Alexandra Beletsi
    Charalambos Milonas
    Neil Branscombe
    Nikos Maniadakis
    BMC Health Services Research, 14
12345